<html>
<head>PUBMED IDs for RNS2</head>
<body bgcolor='#C5F0F2'><h1>RNS2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/2387583/'>Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily.</a> August 1  1990<br><a href='https://pubmed.ncbi.nlm.nih.gov/1577491/'>Localization of the human eosinophil Charcot-Leyden crystal protein (lysophospholipase) gene (CLC) to chromosome 19 and the human ribonuclease 2 (eosinophil-derived neurotoxin) and ribonuclease 3 (eosinophil cationic protein) genes (RNS2 and RNS3) to chromosome 14.</a> May 1  1992<br><a href='https://pubmed.ncbi.nlm.nih.gov/8647842/'>Enhanced expression of the eosinophil-derived neurotoxin ribonuclease (RNS2) gene requires interaction between the promoter and intron.</a> May 24  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/8999843/'>Intronic enhancer activity of the eosinophil-derived neurotoxin (RNS2) and eosinophil cationic protein (RNS3) genes is mediated by an NFAT-1 consensus binding sequence.</a> January 17  1997<br><a href='https://pubmed.ncbi.nlm.nih.gov/9490699/'>The role of transcription factor PU.1 in the activity of the intronic enhancer of the eosinophil-derived neurotoxin (RNS2) gene.</a> April 16  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10534126/'>C/EBP regulates the promoter of the eosinophil-derived neurotoxin/RNS2 gene in human eosinophilic cells.</a> October 26  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/18455749/'>Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death.</a> May 6  2008<br></body></html>
